Sodium stibogluconate (antimony-based)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Sodium stibogluconate (antimony-based), covering 2009-09-09 to 2009-09-09. Get the full timeline:
Most recent: Clinical Trial Update: Reduced Doses of Antimony Plus Ranulocyte Monocyte Colony Stimulating Factor (GM-CSF) for Cutaneous Leishmaniasis [Phase 2]